“Severe hyponatraemia”的搜索结果，显示 371-380 项，共有 10540 项

1. 血液科- 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate the immune and hematopoietic compartments in patients with monoclonal B cell lymphocytosis (MBL) and chronic ...

2. 肾病和高血压- 临床试验- 妙佑医疗国际

   ... severe side effects without providing an acceptable level of clinical benefit. Authorizaton to Use Clincially Obtained Data for Research. Rochester, Minn ...

3. 血液科- 临床试验- 妙佑医疗国际

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

4. 肾病和高血压- 临床试验- 妙佑医疗国际

   ... severe side effects without providing an acceptable level of clinical benefit. OBINUTUZUMAB in Treatment of Fibrillary Glomerulonephritis. Rochester, Minn ...

5. 恰加斯病- 医生与科室

   Thank a researcher today ... Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.

6. 外科 - 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to determine the impact of focused ultrasound (FUS) on the composition of the tumor extracellular microenvironment ...

7. 外科 - 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to determine the impact of focused ultrasound (FUS) on the composition of the tumor extracellular microenvironment ...

8. 血液科- 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate the immune and hematopoietic compartments in patients with monoclonal B cell lymphocytosis (MBL) and chronic ...

9. 血液科- 临床试验- 妙佑医疗国际

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

10. 肺科- 临床试验- 妙佑医疗国际

    Jacksonville, Fla. This phase II trial compares the impact of subcutaneous (SC) nivolumab given in an in-home setting to an in-clinic setting on cancer care and ...